Addendum
Colchicine (prophylaxis of ischaemic cardiovascular events after myocardial infarction) – Addendum to Project A26-16
Report documents
-
Addendum
Colchicine (prophylaxis of ischaemic cardiovascular events after myocardial infarction) – Addendum to Project A26-16
Dossier assessment
Indication:
In addition to standard therapies for prophylaxis of ischaemic cardiovascular events in adult patients with atherosclerotic coronary artery disease and a recent myocardial infarction
Result of dossier assessment:
Unchanged after addendum: hint of a non-quantifiable added benefit
Additional information
Federal Joint Committee (G-BA)
20-08-2026 A G-BA decision was published.
G-BA documents on this decision
Project details
- Project no.
- A26-82
- Commission
- Commission awarded on 07.07.2026 by the Federal Joint Committee (GBA).
- Report type
- Addendum
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Heart and circulation
- Note
-
If the need for additional work on a project commissioned by the GBA arises during consultations, IQWiG submits an addendum. The subsequent decides on the extent of the added benefit concludes the early benefit assessment.
- DOI
https://doi.org/10.60584/A26-82
Connected Projects
-
Dossier assessment
Colchicine (prophylaxis of ischaemic cardiovascular events after myocardial infarction) – Benefit assessment according to §35a Social Code Book V
Status: Commission completed